Full Answer
Is it too late to buy Trulieve stock?
Perhaps the best argument for why it's not too late to buy Trulieve is that the company continues to be a growth machine. Trulieve reported sales of $120.8 million in the second quarter, a 26% jump from the previous quarter and a record high for the company. This growth seems likely to continue, at least in the near term.
Is Trulieve cannabis (TRV) stock a buy or sell?
Trulieve Cannabis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 10 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $76.66, Trulieve Cannabis has a forecasted upside of 201.7% from its current price of $25.41.
Is Trulieve a profitable business?
At the same time, Trulieve is expanding outside of its home state. The company now has operations in four other states: California, Connecticut, Massachusetts, and Pennsylvania. Unlike many of its peers, Trulieve is already consistently profitable.
Is Trulieve the world's most profitable pot Stock?
The company's Q2 adjusted earnings before interest, taxes, depreciation, and amortization ( EBITDA) totaled $60.5 million, marking the tenth consecutive quarter of positive results. Trulieve even ranks as the second most profitable pot stock in the world. Diminishing returns?
See more
Can you buy Trulieve stocks?
Shares of Trulieve cannot be purchased directly from the company, however, stock can be purchased through brokerage firms.
Is Trulieve on the US stock market?
Range: 2022-06-24 09:26:06 to 2022-06-24 16:02:53. The chart has 1 Y axis displaying values. Range: 12.75 to 13.5....Trulieve Cannabis Corp.Volume292.95KMarket Value$2.4BShares Outstanding135MEPS (TTM)-$0.12P/E Ratio (TTM)N/A7 more rows
How much does it cost to buy stock in Trulieve?
What is Trulieve Cannabis' stock price today? One share of TCNNF stock can currently be purchased for approximately $13.02.
Is TCNNF over the counter?
TCNNF:USOTC US. Trulieve Cannabis Corp.
What company owns Trulieve?
CEO, Trulieve Cannabis Corp. Kim Rivers is the CEO of Trulieve, Florida's first and leading medical cannabis company and one of the most profitable American cannabis companies. As CEO, Ms. Rivers directed the construction of the company's cultivation and processing facilities.
Does Trulieve stock pay dividends?
No. Trulieve does not currently pay a dividend or offer a dividend reinvestment plan (DRIP).
Is Trulieve overpriced?
Right now, Trulieve is a little expensive at 9.1 times book value, 8.9 times revenue, and 56 times earnings.
Why is Trulieve stock up?
Trulieve stock was up 3%, to $14, in Thursday morning trading. Shares of state-licensed operators trade over the counter because of marijuana's federal illegality. The March quarter's sales were 64% higher than in the year-earlier quarter's, thanks largely to Trulieve's October merger with Harvest Health & Recreation.
Is Curlf a buy?
According to the issued ratings of 10 analysts in the last year, the consensus rating for Curaleaf stock is Moderate Buy based on the current 2 hold ratings and 8 buy ratings for CURLF.
Is Tcnnf a good investment?
Trulieve Cannabis Corp (OTCQX International:TCNNF) The 19 analysts offering 12-month price forecasts for Trulieve Cannabis Corp have a median target of 46.07, with a high estimate of 95.99 and a low estimate of 16.98. The median estimate represents a +251.71% increase from the last price of 13.10.
What is the stock price for True Leaf?
(TCNNF) Stock Price, News, Quote & History - Yahoo Finance....Performance Outlook.Previous Close13.0252 Week Range12.31 - 39.01Volume194,496Avg. Volume288,7914 more rows
Is Tcnnf a US company?
Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.
Should I buy or sell Trulieve Cannabis stock right now?
9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trulieve Cannabis in the last twelve months. There are currently...
What is Trulieve Cannabis' stock price forecast for 2022?
9 Wall Street analysts have issued 1-year price objectives for Trulieve Cannabis' shares. Their forecasts range from $47.00 to $135.00. On average,...
How has Trulieve Cannabis' stock price performed in 2022?
Trulieve Cannabis' stock was trading at $26.01 at the start of the year. Since then, TCNNF shares have decreased by 46.1% and is now trading at $14...
Are investors shorting Trulieve Cannabis?
Trulieve Cannabis saw a increase in short interest in May. As of May 31st, there was short interest totaling 453,400 shares, an increase of 22.8% f...
When is Trulieve Cannabis' next earnings date?
Trulieve Cannabis is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forecast for...
How were Trulieve Cannabis' earnings last quarter?
Trulieve Cannabis Corp. (OTCMKTS:TCNNF) issued its quarterly earnings results on Monday, November, 15th. The company reported $0.14 EPS for the qua...
What guidance has Trulieve Cannabis issued on next quarter's earnings?
Trulieve Cannabis issued an update on its FY 2022 earnings guidance on Thursday, June, 9th. The company provided earnings per share (EPS) guidance...
Who are Trulieve Cannabis' key executives?
Trulieve Cannabis' management team includes the following people: Ms. Kimberly Rivers , Founder, Chairman & CEO (Age 43, Pay $4.3M) Mr. Alex D'A...
Who are some of Trulieve Cannabis' key competitors?
Some companies that are related to Trulieve Cannabis include Abacus Health Products (ABAHF) , Acreage (ACRGF) , Alliance Growers (ACGWF) , Alth...
Steady Growth for Trulieve Cannabis Stock
Ever since its inception, Trulieve has grown steadily and now holds a 52% share in Florida’s cannabis market. While 79% of its customers are repeat buyers, the company caters to 1,500 new medical cannabis patients on a monthly basis.
Bottom Line: Is Trulieve a Good Stock to Buy?
Trulieve has expanded its national footprint through acquisitions of Solevo Wellness and PurePenn. The company is serious about expanding. On April 7, Trulieve announced that it raised $198.1 million by selling shares at $39.63 before deducting the underwriting discounts and commissions, and other offering expenses.
How much is Trulieve's revenue?
In 2019, Trulieve reported net revenue of $252.8 million, compared with sales of $103 million in 2018, a robust growth of 146% year-over-year. In Q2, its revenue was up 109% at $120.8 million driven by an increase in retail sales. In the first six months of 2020, company sales were up 112% at $216.8 million.
What is Trulieve marijuana?
Trulieve was the first medical marijuana company in Florida, which is the third most populous state in the U.S. The company’s vertically integrated seed-to-sale operation has a 51% market share in Florida. Trulieve has over 500 SKU’s (stock-keeping units) and continues to add new products (such as edibles) and expand its portfolio.
Is Trulieve a profitable company?
Trulieve has a strong balance sheet and is already profitable. The company can use funds to focus on expansion and acquisitions to increase its presence in other states. It does not have to dive into its cash balance to fund ongoing operations, a luxury only a few pot companies have at the moment.
How much is Trulieve stock worth in 2021?
The Trulieve Cannabis Corp stock price gained 0.16% on the last trading day (Thursday, 8th Jul 2021), rising from $37.90 to $37.96. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 4.80% from a day low at $36.26 to a day high of $38.00. The price has fallen in 6 of the last 10 days and is down by -0.52% for this period. Volume fell on the last day by -17 thousand shares and in total, 303 thousand shares were bought and sold for approximately $11.49 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
When will the double bottom go up in 2021?
A buy signal from a double bottom formation was found on Tuesday, June 15 , 2021 and based on theory for this formation the price should go up by 18.95% to $42.58 within 39 trading days since signal was issued (Tuesday, August 10, 2021).
How many dispensaries does Trulieve have?
Trulieve currently operates 59 medical cannabis dispensaries in Florida. It already has stores in all of the biggest cities in the state, plus many other smaller markets. The company will likely reach a point of saturation in Florida in the not-too-distant future.
How many medical marijuana licenses does Trulieve have?
For example, Trulieve's acquisition of Life Essence gives it three medical cannabis licenses and three recreational marijuana licenses in Massachusetts. The state's total cannabis sales are expected to top $1.2 billion next year. Trulieve is also in a strong financial position to expand into more states.
Is Trulieve's growth slowing down?
That's downright cheap. Even better, Trulieve's earnings should increase quite a bit. Yes, Trulieve's growth will eventually slow down in Florida. However, investors shouldn't discount the potential for growth in other states.
Is Trulieve expanding in Florida?
It's adding new stores in the Sunshine State, which could further cement its lead. At the same time, Trulieve is expanding outside of its home state.
Is it too late to buy Trulieve?
Perhaps the best argument for why it's not too late to buy Trulieve is that the company continues to be a growth machine. Trulieve reported sales of $120.8 million in the second quarter, a 26% jump from the previous quarter and a record high for the company.
Is Trulieve a profitable company?
The company now has operations in four other states: California, Connecticut, Massachusetts, and Pennsylvania. Unlike many of its peers, Trulieve is already consistently profitable. It posted net income of $6.6 million in Q2.
Will Trulieve legalize medical marijuana?
Don't overlook the potential impact that changes to federal marijuana laws could have for Trulieve, either. It's quite possible that the November elections could pave the way for the U.S. legalization of medical cannabis, or at least federal recognition of individual state authority to enforce their own recreational marijuana laws.
OTC: TCNNF
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
After a wild 2021, what does this leading U.S. MSO stock have in store for investors?
One of the most frustrating trades of 2021 was in U.S. cannabis stocks. After riding a wave of enthusiasm early in the year on the back of a Democratic electoral victory and hopes for federal legalization, Congress became bogged down in other priorities.
Closing a big deal in October
The big event for Trulieve was closing its massive $2.1 billion acquisition of Harvest Health and Recreation on Oct. 1. Before the deal, Trulieve had pursued a somewhat unusual strategy of concentrating its efforts to dominate a single state: Florida.
Reasons Trulieve could skyrocket
Cannabis stocks have tended to trade almost entirely based on the prospects for federal legislation, so any movement on that front could cause Trulieve and all pot stocks to soar. However, even absent federal legislation, more state-level movement could also be a catalyst.
Why Trulieve could sink
Of course, those competitive pressures and aggressive price discounts from competitors could weigh on Trulieve, even if Trulieve is perhaps the best-equipped MSO to handle it. In addition, if there is some sort of definitive killing of federal legislation on any front, even banking reform, it could hurt sentiment for cannabis stocks in general.
What's more likely?
Given that Trulieve's stock has come all the way back down to where it was around the time of the 2020 election, I don't think there is too much downside here. That's especially true since Trulieve is among the most profitable and cash-rich U.S. cannabis stocks.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, December 31, 2021, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss
Trulieve Cannabis Corp. finds support from accumulated volume at $31.93 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is Trulieve Cannabis Corp. stock A Buy?
Trulieve Cannabis Corp. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
